The Covid Delta mutation is causing major dangling in trade. With infections on the rise in many countries of the world, stocks that have benefited from the release of vaccines have lost momentum in the last month. This could be an opportunity to increase investor exposure to these stocks, according to strategists at JPMorgan Chase & Co., who say key consumer principles remain strong.